25 May 2013
Keywords: barr, plan, approved, over, otc, sale, fda
Article | 04 September 2006
The US Food and Drug Administration has granted over-the-counter marketing permission for New Jersey-based drugmaker Barr
Pharmaceuticals' Plan B (levonorgestrel) ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
4 September 2006
28 August 2006
24 May 2013
© 2013 thepharmaletter.com